Print Page  Close Window

SEC Filings

MYOKARDIA INC filed this Form S-3ASR on 03/08/2018
Entire Document

Table of Contents


Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in City of San Francisco, State of California, on March 8, 2018.





/s/ T. Anastasios Gianakakos


T. Anastasios Gianakakos


President and Chief Executive Officer

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby severally constitutes and appoints each of T. Anastasios Gianakakos and Jacob Bauer, and each of them singly, as such person’s true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign any or all amendments (including, without limitation, post-effective amendments) to this registration statement (or any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933), and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.







/s/ T. Anastasios Gianakakos

  President, Chief Executive Officer and Director (Principal Executive Officer)   March 8, 2018
T. Anastasios Gianakakos    

/s/ Jacob Bauer

  Senior Vice President, Finance and Corporate Development (Principal Financial and Accounting Officer)   March 8, 2018
Jacob Bauer    

/s/ Sunil Agarwal, M.D.

  Director   March 8, 2018
Sunil Agarwal, M.D.    

/s/ Mary B. Cranston

  Director   March 8, 2018
Mary B. Cranston    

/s/ David P. Meeker, M.D.

  Director   March 8, 2018
David P. Meeker, M.D.    

/s/ Mark L. Perry

  Director   March 8, 2018
Mark L. Perry